Real-world evidence on infection risks from multiple sclerosis treatments remains limited, with inconsistent findings ...

Rising metabolic score for insulin resistance (METS-IR) levels strongly correlate with major cardiovascular events (MACE) and ...

In advanced non–small cell lung cancer (NSCLC), discontinuing immunotherapy after 2 years can maintain durable responses ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Making treatment for non–small cell lung cancer (NSCLC) accessible to a wide range of the population can help to improve ...

A qualitative study found strong support for primary care provider–nephrologist comanagement of chronic kidney disease (CKD), ...

The humanized IgG4 monoclonal antibody was first approved for myasthenia gravis in the US in 2023, with approvals in Japan ...

US adults who were displaced and never returned home due to a natural disaster had the highest odds of developing depression or anxiety.

A new study finds that drugmakers’ use of overlapping patents delayed generic entry for 4 top-selling drugs, driving billions in excess spending.